220:. But it seems to me that the sequencing method, at least for now, is more notable than its developers (who I suspect are not its only users), and that both can be covered by one article- in this case simply the larger one. A new PB could still be made, of course, I'd hope it is not simply another verbatim copy
324:, who was in fact one of the people involved in developing the technology, so it might well be notable. I havent checked his actual role in the work, though & the site does not claim him to be the inventor. The sequencing method is very notable, butt hat doesn't carry over to everyone involved with it.
186:
as I don't see how this company is non-notable. Also, if the technology the company has pioneered is worthy of it's own article, why isn't the company itself? I'm still trying to decide if I'm a deletionist or inclusionist, but will lean inclusionistically until I can figure out which I am, hence
320:
thing to check' I'll let another admin confirm and delete this. There might or might not be an article to be written about them, depending upon whether they have a product or are merely planning to have one. The company was in fact founded by
Stephen Turner
241:
Hmm, good point. I like the chicken or the egg analogy for this. I see what you're saying regarding the technology vs the company, and I think I'll change my vote, especially if the only substantial content that the company's article could gain would be
137:
104:
99:
108:
148:
which it is a smaller but substantial reiteration of; notability is one concern
Article is also an unreferenced orphan requiring cleanup.
246:
224:
145:
91:
267:
197:
17:
191:, I may reconsider, though, since I tend to lean deletionistically when it comes to notability. (Did I just invent some words? :P) ~
379:
36:
364:
335:
303:
277:
236:
207:
175:
157:
73:
299:
378:
Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a
95:
35:
Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a
188:
272:
202:
171:
232:
153:
295:
348:
87:
79:
358:
67:
322:
262:
192:
167:
29:
The following discussion is an archived debate of the proposed deletion of the article below.
228:
149:
342:
47:
57:
314:
291:
352:
331:
61:
53:
125:
326:
347:
per DGG. Copy-and-paste from the abovementioned web page, which is
372:
The above discussion is preserved as an archive of the debate.
144:
Company's main product already covered by unassessed article
187:
this position. If you expound upon your nom with respect to
243:
221:
132:
121:
117:
113:
316:
and so marked. When spam like this shows up, its the
292:
http://www.pacificbiosciences.com/index.php?q=about
216:Perhaps the company is more notable. Really it's
39:). No further edits should be made to this page.
382:). No further edits should be made to this page.
8:
18:Knowledge (XXG):Articles for deletion
7:
247:Single Molecule Real Time Sequencing
225:Single Molecule Real Time Sequencing
146:Single Molecule Real Time Sequencing
60:, respectively. Non-admin closure.
24:
294:User below me beat me to it! :)
290:Start-up company = not notable.
349:blatant copyright infringement
1:
365:08:04, 7 November 2008 (UTC)
336:05:54, 7 November 2008 (UTC)
304:05:52, 7 November 2008 (UTC)
278:05:41, 7 November 2008 (UTC)
237:04:33, 7 November 2008 (UTC)
208:04:08, 7 November 2008 (UTC)
176:03:04, 7 November 2008 (UTC)
158:03:02, 7 November 2008 (UTC)
74:17:36, 7 November 2008 (UTC)
399:
311:Speedy Delete as copyvio
375:Please do not modify it.
32:Please do not modify it.
261:, changed from above. ~
249:article, as you linked.
52:not once, but twice by
218:the chicken or the egg
313:of their about page
88:Pacific Biosciences
80:Pacific Biosciences
390:
377:
361:
355:
275:
270:
265:
205:
200:
195:
135:
129:
111:
70:
64:
44:The result was
34:
398:
397:
393:
392:
391:
389:
388:
387:
386:
380:deletion review
373:
359:
353:
341:Speedy delete (
296:ChildofMidnight
273:
268:
263:
203:
198:
193:
131:
102:
86:
83:
68:
62:
46:speedy delete (
37:deletion review
30:
22:
21:
20:
12:
11:
5:
396:
394:
385:
384:
368:
367:
338:
307:
306:
280:
255:
254:
253:
252:
251:
250:
211:
210:
179:
178:
160:
142:
141:
82:
77:
42:
41:
25:
23:
15:
14:
13:
10:
9:
6:
4:
3:
2:
395:
383:
381:
376:
370:
369:
366:
362:
356:
350:
346:
344:
339:
337:
333:
329:
328:
323:
319:
315:
312:
309:
308:
305:
301:
297:
293:
289:
286:
285:
281:
279:
276:
271:
266:
260:
257:
256:
248:
244:
240:
239:
238:
234:
230:
226:
222:
219:
215:
214:
213:
212:
209:
206:
201:
196:
190:
185:
184:
180:
177:
173:
169:
166:
163:
162:
161:
159:
155:
151:
147:
139:
134:
127:
123:
119:
115:
110:
106:
101:
97:
93:
89:
85:
84:
81:
78:
76:
75:
71:
65:
59:
55:
51:
49:
40:
38:
33:
27:
26:
19:
374:
371:
340:
325:
317:
310:
287:
283:
282:
258:
217:
182:
181:
164:
143:
45:
43:
31:
28:
229:Synchronism
168:Melia Nymph
150:Synchronism
189:notability
58:NawlinWiki
242:redundant
183:Weak Keep
354:MuZemike
274:andahalf
204:andahalf
138:View log
63:MuZemike
54:Cenarium
245:in the
105:protect
100:history
288:speedy
284:Delete
259:Delete
165:Delete
133:delete
109:delete
318:first
136:) – (
126:views
118:watch
114:links
16:<
360:talk
332:talk
300:talk
233:talk
172:talk
154:talk
122:logs
96:talk
92:edit
69:talk
56:and
343:G12
327:DGG
264:Pip
223:of
194:Pip
48:G12
363:)
351:.
334:)
302:)
235:)
174:)
156:)
124:|
120:|
116:|
112:|
107:|
103:|
98:|
94:|
72:)
357:(
345:)
330:(
298:(
269:2
231:(
227:.
199:2
170:(
152:(
140:)
130:(
128:)
90:(
66:(
50:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.